Hemispherx BioPharma Inc (AMEX: HEB) surged up 4.86% to $0.279 on a
traded volume of 761k shares. The Rosen Law Firm reminds investors of
the important February 22, 2013 lead plaintiff deadline in the class
action filed on behalf of investors who purchased the securities of
Hemispherx Biopharma Inc from March 19, 2012 through December 17, 2012.
Hemispherx Biopharma is a specialty pharmaceutical company engaged in
the clinical development of new drugs therapies based on natural immune
system enhancing technologies for the treatment of viral and immune
based chronic disorders.
https://killer.sh Pre Setup Once you've gained access to your terminal it might be wise to spend ~1 minute to setup your environment. You could set these: alias k = kubectl # will already be pre-configured export do = "--dry-run=client -o yaml" # k get pod x $do export now = "--force --grace-period 0" # k delete pod x $now Vim To make vim use 2 spaces for a tab edit ~/.vimrc to contain: set tabstop=2 set expandtab set shiftwidth=2 More setup suggestions are in the tips section . Question 1 | Contexts Task weight: 1% You have access to multiple clusters from your main terminal through kubectl contexts. Write all those context names into /opt/course/1/contexts . Next write a command to display the current context into /opt/course/1/context_default_kubectl.sh , the command should use kubectl . Finally write a second command doing the same thing into ...
ReplyDeleteHemispherx BioPharma, Inc. (NYSE: HEB) shares rallied over 17 percent on almost double the average daily volume Wednesday. The Prescription Drug User Fee Act review goal for the FDA to complete its review of the NDA for Ampligen is February 2, 2013.